Clinical observation of internal radiotherapy using 89Sr 99Tc-MDP and zoledronic acid in the treatment and pain relief of lung cancer patients with bone metastasis

Chinese Journal of Clinical Oncology

Volumn 39, Issue 21, 2012, Pages 1660-1662

  Dong, Zhanfei ^a   Qing, Yongde ^a   Wang, Xinhua ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

99Tc MDP; Bone neoplasm therapy; Lung neoplasm; Strontium 89; Zoledronic acid

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; STRONTIUM 89; ZOLEDRONIC ACID;

ANALGESIA; ARTICLE; BONE METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; QUALITY OF LIFE;

EID: 84872575730     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2012.21.024     Document Type: Article

References (10)

1. Coscia M, Quaglino E, Iezzi M, et al. Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway[J]. J Cell Mol Med, 2010,14(12):2803-2815.